calibrant technology investor information

Latest News

 




Gemini™ data is analyzed by a custom high-throughput bioinformatics platform, Proteome BiNDR™. Peptide and protein identifications and quantifications are made within BiNDR™ and correlated with physical properties including mass, sequence, isoelectric point, and relative hydrophobicity. All sample information is tied to the analytical data, allowing cross comparison between unlimited numbers of samples. A key proprietary feature of the BiNDR™ platform is a robust and proven algorithm which ensures exceptionally high-confidence data, allowing the statistical significance of discovered targets and markers to be readily evaluated within the context of biological pathways and protein networks.

 

 

 

 
Home | About | Biomarkers | Gemini | Partners | News & Events | Contact
© Calibrant Biosystems. All rights reserved. Site Map
home About Technology